SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David Smith who wrote (68347)10/27/1999 10:10:00 PM
From: kha vu  Read Replies (1) of 120523
 
PCOP:
<<< Pharmacopeia (NasdaqNM:PCOP - news)
shares rose about 26 percent on Wednesday after the drug research products
firm showed a surprise profit in the third quarter.

Stock in the Princeton, N.J.-based company rose 2-13/16 to 13-1/2, making it
one of Nasdaq's top percentage gainers, with trade volume heavy at over 625,000 shares.

The firm late Tuesday reported third-quarter net income of 2 cents per diluted share, compared with a loss of
11 cents a year earlier. The recent third-quarter earnings rose on higher sales of software and laboratory
services, the firm said.

As a result, Deutsche Banc Alex. Brown early Wednesday raised its 1999 fiscal year earnings per share
estimates for the company to 16 cents from 10 cents. It also raised fiscal year 2000 and 2001 estimates to 31
cents from 28 cents and 51 cents from 49 cents, respectively.

Deutsche Banc Alex. Brown said it expected the company's financial performance to continue to be driven by
strong software and drug discovery services revenue growth.>>>
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext